Egg yolk phosphatidylcholine alleviates DSS-induced colitis in Balb/c mice

Yunpeng Wen,Lixin Tan,Shuping Chen,Na Wu,Yao Yao,Lilan Xu,Mingsheng Xu,Yan Zhao,Yonggang Tu
DOI: https://doi.org/10.1039/d3fo02885b
IF: 6.3173
2023-09-14
Food & Function
Abstract:Ulcerative colitis (UC) is a common inflammatory bowel disease whose incidence is on the rise worldwide. The drugs commonly used for UC are often associated with a number of side effects. Therefore, the development of an effective, food-borne substances for UC is in line with current needs. Egg yolk phosphatidylcholine (EYPC) is one of the more abundant lipids in egg yolk and possesses various biological activities. However, its protective effect against UC has not been clarified. In this study, the anti-UC activity of EYPC was investigated using a dextran sodium sulfate (DSS)-induced colitis model in Balb/c mice. The results showed that EYPC supplementation inhibited DSS-induced colon shortening, spleen index and disease activity index increasing and intestinal structural damage. EYPC could down-regulate the levels of TNF-α, IL-1β, IL-6 and MPO in colon, and restore the number of goblet cells and the level of tight junction proteins. Besides, EYPC modulated the composition of the gut microbiota, lowered the relative abundance of the pathogenic bacterium Parabacteroides and upregulated the abundance of the beneficent bacteria Alistipes and Lachnospiraceae_ NK4A136_ groups. These results evidenced that EYPC could attenuate DSS-induced colitis in mice and had the potential to prevent and treat UC.
biochemistry & molecular biology,food science & technology
What problem does this paper attempt to address?